Receptor-mediated Endocytosis 8 Utilizes an N-terminal Phosphoinositide-binding Motif to Regulate Endosomal Clathrin Dynamics
Overview
Authors
Affiliations
Receptor-mediated endocytosis 8 (RME-8) is a DnaJ domain containing protein implicated in translocation of Hsc70 to early endosomes for clathrin removal during retrograde transport. Previously, we have demonstrated that RME-8 associates with early endosomes in a phosphatidylinositol 3-phosphate (PI(3)P)-dependent fashion. In this study, we have now identified amino acid determinants required for PI(3)P binding within a region predicted to adopt a pleckstrin homology-like fold in the N terminus of RME-8. The ability of RME-8 to associate with PI(3)P and early endosomes is largely abolished when residues Lys(17), Trp(20), Tyr(24), or Arg(26) are mutated resulting in diffuse cytoplasmic localization of RME-8 while maintaining the ability to interact with Hsc70. We also provide evidence that RME-8 PI(3)P binding regulates early endosomal clathrin dynamics and alters the steady state localization of the cation-independent mannose 6-phosphate receptor. Interestingly, RME-8 endosomal association is also regulated by the PI(3)P-binding protein SNX1, a member of the retromer complex. Wild type SNX1 restores endosomal localization of RME-8 W20A, whereas a SNX1 variant deficient in PI(3)P binding disrupts endosomal localization of wild type RME-8. These results further highlight the critical role for PI(3)P in the RME-8-mediated organizational control of various endosomal activities, including retrograde transport.
DNAJC13 localization to endosomes is opposed by its J domain and its disordered C-terminal tail.
Adoff H, Novy B, Holland E, Lobingier B bioRxiv. 2025; .
PMID: 39763938 PMC: 11702692. DOI: 10.1101/2024.12.19.629517.
Endosomal traffic disorders: a driving force behind neurodegenerative diseases.
Dong J, Tong W, Liu M, Liu M, Liu J, Jin X Transl Neurodegener. 2024; 13(1):66.
PMID: 39716330 PMC: 11667944. DOI: 10.1186/s40035-024-00460-7.
Treutlein J, Einenkel K, Kramer B, Awasthi S, Gruber O Eur Arch Psychiatry Clin Neurosci. 2024; 275(2):499-510.
PMID: 39417891 DOI: 10.1007/s00406-024-01905-w.
An engineered trafficking biosensor reveals a role for DNAJC13 in DOR downregulation.
Novy B, Dagunts A, Weishaar T, Holland E, Adoff H, Hutchinson E Nat Chem Biol. 2024; 21(3):360-370.
PMID: 39223388 PMC: 11867885. DOI: 10.1038/s41589-024-01705-2.
Dysregulation of SNX1-retromer axis in pharmacogenetic models of Parkinson's disease.
Yoshida S, Hasegawa T, Nakamura T, Sato K, Sugeno N, Ishiyama S Cell Death Discov. 2024; 10(1):290.
PMID: 38886344 PMC: 11183211. DOI: 10.1038/s41420-024-02062-8.